Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia
about
Early interventions in risk groups for schizophrenia: what are we waiting for?Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness.Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice.Myelination of parvalbumin interneurons: a parsimonious locus of pathophysiological convergence in schizophreniaHigh-resolution copy number variation analysis of schizophrenia in Japan.Identification of RELN variation p.Thr3192Ser in a Chinese family with schizophreniaIncreased GABAB receptor signaling in a rat model for schizophrenia.Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms.Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics.Advances in the genetics of schizophrenia: toward a network and pathway view for drug discovery.Are Hallucinations Due to an Imbalance Between Excitatory and Inhibitory Influences on the Brain?The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia.Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects.Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective.The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability.A genomic lifespan program that reorganises the young adult brain is targeted in schizophrenia.Treating the placenta to prevent adverse effects of gestational hypoxia on fetal brain development.Schizophrenia and the neurodevelopmental continuum:evidence from genomicsSchizophrenia copy number variants and associative learningImmuno-psychiatry: an agenda for clinical practice and innovative research.What can we learn from the high rates of schizophrenia in people with 22q11.2 deletion syndrome?Integrated Bayesian analysis of rare exonic variants to identify risk genes for schizophrenia and neurodevelopmental disorders.Modulating Neuroinflammation to Treat Neuropsychiatric Disorders.Hippocampal Regulation of Postsynaptic Density Homer1 by Associative Learning.The effect of ketamine on the consolidation and extinction of contextual fear memory.Rodent models of genetic and chromosomal variations in psychiatric disorders.The role of white matter microstructure in inhibitory deficits in patients with schizophrenia.Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.Marker chromosome genomic structure and temporal origin implicate a chromoanasynthesis event in a family with pleiotropic psychiatric phenotypes.GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.Antipsychotic drugs: challenges and future directions.A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzymeAssociation Analysis of Somatic Copy Number Alteration Burden With Breast Cancer SurvivalResting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages
P2860
Q26747545-D6030981-0AC5-4BB4-BA84-95A9B2AE045FQ30008997-27B73EB1-3640-4D09-8528-94FF63583AC5Q30359319-A8D1819F-1694-4652-B840-5BAE55C9D879Q33629435-3E624242-9B87-4CA2-8918-151C7AAC14DDQ34528802-864E79B2-B081-426B-BC7D-3CB41BEA2E21Q36793075-9FA26938-0827-49DF-B4BF-1A1F336A67B8Q37298602-90E50E5A-D2F7-41D9-A7F4-A516BBCA324BQ38637625-B07D9799-55F6-45E6-BFAC-2BC606E9023BQ38767128-E2747AFE-2E67-4C2A-BBC7-BCDBE2FE4CC3Q38816605-7FC73DE4-E513-42AF-9187-EA3F5B6B4B86Q38853959-7CF8EAE0-E780-4462-A9D9-E6C174E88D25Q38976291-05B1C71E-A7E3-4E45-B439-CEE24E6814DCQ39203598-7FA90440-CC61-4FA3-AC3F-B373738D1079Q39217627-8377912C-0302-4A96-AFA8-CCE96ED78C08Q39257224-D7306D46-F729-4AA5-9E1B-393BA251B3D3Q40145512-1187DD86-449C-44A0-9F96-99DC67A84E62Q41221537-32455C84-FECD-4513-95C9-5C036531563DQ41489996-2BCB6AD4-0769-419B-B1C2-BC06ACCBC905Q41658777-0016A625-C510-4D5E-B696-C1476A76FF5CQ42325307-05BC2CCC-0A38-4330-A755-7A3682F387DEQ42378870-F23EAC9D-55D4-4A06-835C-966EB177D121Q42544634-9EE13F9E-CDB2-454D-9354-BC9172C477D5Q47138547-7A9C5E54-E8F6-40DE-99C6-985D49B99374Q47140966-A9D8D87A-A6C7-42D6-9419-290F7C1EA1E1Q47162671-AEA02E1D-AB53-4837-8EE3-8828D4E8CE7AQ47555330-20E86B2B-9DFE-4C6E-BD8E-774F42ECC80EQ48257043-325DAEB4-6BBF-4439-B20F-B335F3626C21Q48422920-0AE1F986-7363-449F-80EC-4BA04B1D3060Q50301210-C014EF79-AAF3-4D14-9A25-F5E1FCAB277AQ52562177-2BE331D1-A772-4775-BACB-7727D665AA29Q53428761-095C8E1D-2ADB-40EF-9E7E-BEA9AC098EF3Q54995596-2A3E46E0-DC4B-4A6E-89C3-FAFBC0282793Q57811369-133DA8E9-7ADB-4239-9C9B-DC3BEE38A779Q58592626-F22CE839-80FB-4EA7-B2B0-18BC9D602133Q59129268-91FCD2DD-5A37-4C5A-9831-2FA873A7AA9C
P2860
Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Novel Findings from CNVs Impli ...... ing Complexes in Schizophrenia
@ast
Novel Findings from CNVs Impli ...... ing Complexes in Schizophrenia
@en
Novel Findings from CNVs Impli ...... ing Complexes in Schizophrenia
@nl
type
label
Novel Findings from CNVs Impli ...... ing Complexes in Schizophrenia
@ast
Novel Findings from CNVs Impli ...... ing Complexes in Schizophrenia
@en
Novel Findings from CNVs Impli ...... ing Complexes in Schizophrenia
@nl
prefLabel
Novel Findings from CNVs Impli ...... ing Complexes in Schizophrenia
@ast
Novel Findings from CNVs Impli ...... ing Complexes in Schizophrenia
@en
Novel Findings from CNVs Impli ...... ing Complexes in Schizophrenia
@nl
P2093
P2860
P50
P3181
P1433
P1476
Novel Findings from CNVs Impli ...... ing Complexes in Schizophrenia
@en
P2093
David H Kavanagh
Kimberly D Chambert
Michael J Owen
Steven A McCarroll
P2860
P304
P3181
P356
10.1016/J.NEURON.2015.04.022
P407
P50
P577
2015-06-03T00:00:00Z